<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if IE ]> <html class="no-js IE"> <![endif]-->
<!--[if IE ]> <html class="no-js IE"> <![endif]-->
<!--[if gt IE 8]><!--> <html class="no-js"> <!--<![endif]-->
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <title></title>
        <meta name="description" content="">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <link rel="stylesheet" href="css/styles.css">
        <link rel="stylesheet" href="css/customStyles.css">
    </head>
    <body class="breastCancer">
        <div id="header">
            <div class="header agilvaxLogoSmallScreen center">
                <a href="index.html"><img src="images/agilvaxHeaderLogo.png" alt="Agilvax" title="Agilvax" width="135"></a>
            </div>

            <div class="navigation">
                    <div class="mobileNavToggle">Menu</div>
                    <div class="navigationBar">
                        <ul class="nav navLeft">
                        </ul><!-- /nav -->
                        <ul class="nav navRight">
                        </ul><!-- /nav -->
                    </div><!-- /navigationBar -->
            </div><!-- /navigation -->
        </div><!-- #header -->

        <div class="pageTitle">
            <div class="containerNarrow">
                <h1 class="slideInBT">Breast Cancer</h1>
            </div>
        </div><!-- /pageTitle -->
        <div class="mainContent">
            <div class="containerNarrow">
                <div class="intro">
                    <p>Breast cancer is the most common cancer in women in both the developed and developing worlds.</p>
                </div><!-- /intro -->
                <div class="circlesAndTextWrapper breakColMobile">
                    <div class="circles statsCircles center">
                        <div class="oneThird circleWrapper">
                            <div class="greenCard">
                                <div class="circle">
                                    <h2 class="cTopInfo">500,000</h2>
                                    <span class="cBottomInfo"><p>deaths</p></span>
                                </div><!-- /circle -->
                                <div class="circleText"><p>It is estimated that breast cancer is responsible for over 500,000 deaths each year worldwide.</p></div>
                            </div><!-- /greenCard -->
                        </div><!-- /oneThird circleWrapper -->

                        <div class="oneThird circleWrapper">
                            <div class="greenCard">
                                <div class="pieChartCircle">
                                </div>                            
                                <svg xmlns="http://www.w3.org/2000/svg" width="160" height="160" aria-label="A chart." aria-hidden="true" style="overflow: hidden;"><defs id="defs"/><rect x="0" y="0" width="160" height="160" stroke="none" stroke-width="0" fill="#ffffff" fill-opacity="0"/><g><path d="M80,80L80,152A72,72,0,0,1,80,8L80,80A0,0,0,0,0,80,80" stroke="#ffffff" stroke-width="1" fill="#dfeef0"/></g><g><path d="M80,80L80,8A72,72,0,0,1,80,152L80,80A0,0,0,0,0,80,80" stroke="#ffffff" stroke-width="1" fill="#55aab4"/></g><g/></svg>
                                <div class="circleText piechartText"><p>Nearly <b>50%</b> of all breast cancer cases occur in less developed countries.</p></div>
                            </div><!-- /greenCard -->
                        </div><!-- /oneThird circleWrapper -->

                        <div class="oneThird circleWrapper gridLast">
                            <div class="greenCard">
                                <div class="pieChartCircle">
                                </div>                            
                                <svg xmlns="http://www.w3.org/2000/svg" width="160" height="160" aria-label="A chart." aria-hidden="true" style="overflow: hidden;"><defs id="defs"/><rect x="0" y="0" width="160" height="160" stroke="none" stroke-width="0" fill="#ffffff" fill-opacity="0"/><g><path d="M80,80L45.31373546467652,143.09408096315818A72,72,0,0,1,80,8L80,80A0,0,0,0,0,80,80" stroke="#ffffff" stroke-width="1" fill="#dfeef0"/></g><g><path d="M80,80L80,8A72,72,0,1,1,45.31373546467652,143.09408096315818L80,80A0,0,0,1,0,80,80" stroke="#ffffff" stroke-width="1" fill="#55aab4"/></g><g/></svg>
                                <div class="circleText piechartText"><p><b>58%</b> of deaths caused by breast cancer, occur in less developed countries.</p></div>
                            </div><!-- /greenCard -->
                        </div><!-- /oneThird circleWrapper gridLast -->

                    </div><!-- /circlesAndTextWrapper -->
                </div>
                <p class="clear">Breast cancer survival rates vary greatly throughout the world, ranging from 80% in North America, to below 40% in low-income countries. The low survival rates in less developed countries are primarily due to the lack of early detection programs, which results in a high proportion of women presenting with late-stage disease, as well as the lack of adequate diagnosis and treatment facilities (World Health Organization, Breast Cancer Prevention and Control 2014).</p>

                <h2>Triple Negative Breast Cancer</h2>
                <p>Despite marked advancement in breast cancer treatment and detection, 20-30% of breast cancer patients relapse, often with cancer found in distal organs. Aggressive forms of breast cancer that lack the markers estrogen, progesterone and HER2 (triple negative breast cancer, TNBC) account for 15-20% of all breast cancers in the US. These cancers disproportionally affect young woman and minorities and have higher rates of relapse and poorer outcomes than other forms of breast cancer.</p>
                <p>TNBC are resistant to targeted therapies use to treat other types of breast cancer.  TNBC contain a high frequency of cancer stems cells. While these cells represent a small fraction of cancer cells found in the tumor, they are responsible for most of the cancer spread and relapse. Therefore, effective treatments for TNBC must also target cancer stem cells.</p>

                <div class="card AgilvaxSolution slideInBT">
                <h2>The Agilvax Solution for Breast Cancer</h2>
                <p>Agilvax is developing AX09 as the lead immunotherapy candidate for the treatment of aggressive forms of breast cancer.  Immunization with AX09 elicits antibodies targeting breast cancer stem cells, a key cellular reservoir for relapse, metastatic progression and therapeutic resistance. In preclinical models, AX09 treatment results in a significant reduction in metastatic lesions and has increased efficacy in combination with breast cancer chemotherapeutic agents.  Agilvax is further refining AX09 to enhance its efficacy for the treatment of breast cancer.</p>
                </div><!-- /card -->
            </div><!-- /containerNarrow -->
        </div><!-- /MainContent -->
       


        <div id="footer">
        </div><!-- /footer -->

        <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"></script>
        <script src="http://ajax.googleapis.com/ajax/libs/jqueryui/1.10.4/jquery-ui.min.js"></script>
        <script src="js/modernizr-2.6.2.min.js"></script>
        <script src="js/plugins.js"></script>

        <!-- LoadIncludes -->
        <script>
            $( ".navLeft" ).load( "includes/nav.html" );
            $( ".navRight" ).load( "includes/navRight.html" );
            $( "#footer" ).load( "includes/footer.html" );
        </script>
        <script src="js/main.js"></script>

    </body>
</html>
